On June 2,2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the FDA for vulvovaginal candidiasis (VVC) in adult women and girls who have begun menstruating.
Drug Topics July 2021
Money isn’t everything in this profession.
Pharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.
Become an expert in naloxone to help educate patients.
Pharmacists reflect on their takeaways from the experience and how to move forward.
Administering pediatric immunizations can be a window of opportunity for pharmacists to demonstrate their value.
Pharmacists must keep up to date with the latest in irritable bowel syndrome management.
Advertisement
Advertisement
Trending on Drug Topics
1
Gaps Between Expectations and Effects on Long COVID Contribute to Trust in Vaccines
2
Cardiovascular Disease Rates Increase for Patients With Mental Disorders During COVID-19 Pandemic
3
American Pharmacists Month: How Community Pharmacy Innovation Relies on Expansion, Collaboration
4
How Pharmacies’ Ability to Provide Behavioral Health Services is Growing | NCPA 2025
5
